Effects of estrogen replacement and lower androgen status on skeletal muscle collagen and myofibrillar protein synthesis in postmenopausal women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 10, 2012, Pages 1005-1013

  Hansen, Mette ^a,b   Skovgaard, Dorthe ^a   Reitelseder, Søren ^a   Holm, Lars ^a   Langbjerg, Henning ^a   Kjaer, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aging; Extracellular matrix; Hormone replacement therapy; Human

Indexed keywords

ANDROGEN; COLLAGEN; ESTRADIOL; MUSCLE PROTEIN; SEX HORMONE BINDING GLOBULIN;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ESTROGEN THERAPY; EXERCISE; FEMALE; HUMAN; HYSTERECTOMY; METABOLISM; MIDDLE AGED; OVARIECTOMY; PHYSIOLOGY; POSTMENOPAUSE; SKELETAL MUSCLE;

AGED; ANDROGENS; CASE-CONTROL STUDIES; COLLAGEN; CROSS-SECTIONAL STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; OVARIECTOMY; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN;

EID: 84866099952     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls007     Document Type: Article

References (69)

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on defi nition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-423.
2. Landers KA, Hunter GR, Wetzstein CJ, Bamman MM, Weinsier RL. The interrelationship among muscle mass, strength, and the ability to perform physical tasks of daily living in younger and older women. J Gerontol A Biol Sci. 2001;56:B443-B448. (Pubitemid 32954224)
3. Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, Verhaar HJ. Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing. 2000;29:235-242. (Pubitemid 30316208)
4. Pollanen E, Sipila S, Alen M, et al. Differential infl uence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and post-menopausal women. Aging Cell. 2011;10:650-660.
5. Maltais ML, Desroches J, Dionne IJ. Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact. 2009;9: 186-197.
6. Kallman DA, Plato CC, Tobin JD. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol. 1990;45:M82-M88. (Pubitemid 20171148)
7. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond). 1993;84:95-98. (Pubitemid 23023845)
8. Wiik A, Ekman M, Johansson O, Jansson E, Esbjornsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem Cell Biol. 2009;131:181-189.
9. Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR. Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med. 2001;10:785-795. (Pubitemid 33062088)
10. Greising SM, Baltgalvis KA, Lowe DA, Warren GL. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2009;64A:1071-1081.
11. Fisher JS, Hasser EM, Brown M. Effects of ovariectomy and hindlimb unloading on skeletal muscle. J Appl Physiol. 1998;85:1316-1321. (Pubitemid 28465058)
12. McClung JM, Davis JM, Wilson MA, Goldsmith EC, Carson JA. Estrogen status and skeletal muscle recovery from disuse atrophy. J Appl Physiol. 2006;100:2012-2023. (Pubitemid 43845877)
13. Hayden JM, Bergen WG, Merkel RA. Skeletal muscle protein metabolism and serum growth hormone, insulin, and cortisol concentrations in growing steers implanted with estradiol-17 beta, trenbolone acetate, or estradiol-17 beta plus trenbolone acetate. J Anim Sci. 1992;70: 2109-2119.
14. Sitnick M, Foley AM, Brown M, Spangenburg EE. Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass. J Appl Physiol. 2006;100:286-293. (Pubitemid 43671120)
15. Brown M, Foley A, Ferreria JA. Ovariectomy, hindlimb unweighting, and recovery effects on skeletal muscle in adult rats. Aviat Space Environ Med. 2005;76:1012-1018. (Pubitemid 41619123)
16. Toth MJ, Poehlman ET, Matthews DE, Tchernof A, MacCoss MJ. Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats. Am J Physiol Endocrinol Metab. 2001; 280:E496-E501.
17. Taaffe DR, Newman AB, Haggerty CL, et al. Estrogen replacement, muscle composition, and physical function: The Health ABC Study. Med Sci Sports Exerc. 2005;37:1741-1747. (Pubitemid 41567248)
18. Ronkainen PH, Kovanen V, Alen M, et al. Postmenopausal hormone replacement therapy modifi es skeletal muscle composition and function: a study with monozygotic twin pairs. J Appl Physiol. 2009;107:25-33.
19. Jensen J, Christiansen C, Rodbro P. Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women. Maturitas. 1986;8:209-216. (Pubitemid 17170487)
20. Taaffe DR, Sipila S, Cheng S, Puolakka J, Toivanen J, Suominen H. The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin Physiol Funct Imaging. 2005;25:297-304. (Pubitemid 41223534)
21. Teixeira PJ, Going SB, Houtkooper LB, et al. Resistance training in postmenopausal women with and without hormone therapy. Med Sci Sports Exerc. 2003;35:555-562. (Pubitemid 36417843)
22. Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res. 2001;9:622-626. (Pubitemid 33603873)
23. Pollanen E, Ronkainen PH, Suominen H, et al. Muscular transcriptome in postmenopausal women with or without hormone replacement. Rejuvenation Res. 2007;10:485-500.
24. Hansen RD, Raja C, Baber RJ, Lieberman D, Allen BJ. Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetol. 2003; 40(suppl 1):S191-S195. (Pubitemid 37322752)
25. Toth MJ, Sites CK, Matthews DE. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy. Am J Physiol Endocrinol Metab. 2006;291:E639-E646. (Pubitemid 44352272)
26. Brown M, Birge SJ, Kohrt WM. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol A Biol Sci. 1997;52:B166-B170. (Pubitemid 27235339)
27. Dieli-Conwright CM, Spektor TM, Rice JC, Sattler FR, Schroeder ET. Infl uence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women. J Appl Physiol. 2009;107:1381-1388.
28. Enns DL, Tiidus PM. Estrogen infl uences satellite cell activation and proliferation following downhill running in rats. J Appl Physiol. 2007;104:347-353. (Pubitemid 351232950)
29. Enns DL, Iqbal S, Tiidus PM. Oestrogen receptors mediate oestrogen-induced increases in post-exercise rat skeletal muscle satellite cells. Acta Physiol (Oxf). 2008;194:81-93.
30. Suetta C, Hvid LG, Justesen L, et al. Effects of aging on human skeletal muscle after immobilization and retraining. J Appl Physiol. 2009;107: 1172-1180.
31. Bamman MM, Hill VJ, Adams GR, et al. Gender differences in resistance-training-induced myofi ber hypertrophy among older adults. J Gerontol A Biol Sci Med Sci. 2003;58:108-116. (Pubitemid 36222811)
32. Ivey FM, Roth SM, Ferrell RE, et al. Effects of age, gender, and myo-statin genotype on the hypertrophic response to heavy resistance strength training. J Gerontol A Med Sci. 2000;55:M641-M648. (Pubitemid 32010309)
33. Smith GI, Atherton P, Villareal DT, et al. Differences in muscle protein synthesis and anabolic signaling in the postabsorptive state and in response to food in 65 - 80 year old men and women. PLoS One. 2008; 3:e1875.
34. Doessing S, Heinemeier KM, Holm L, et al. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol. 2009;588: 341-351.
35. Hansen M, Kongsgaard M, Holm L, et al. Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women. J Appl Physiol. 2009;106: 1385-1393.
36. Leung KC, Doyle N, Ballesteros M, et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci U S A. 2003;100:1016-1021. (Pubitemid 36183947)
37. Aadahl M, Jorgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003;35: 1196-1202. (Pubitemid 36807983)
38. Miller BF, Olesen JL, Hansen M, et al. Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise. J Physiol. 2005;567:1021-1033. (Pubitemid 41387842)
39. Hansen M, Langberg H, Holm L, et al. Effect of administration of oral contraceptives on the synthesis and breakdown of myofi brillar proteins in young women. Scand J Med Sci Sports. 2011;21:62-72.
40. Babraj JA, Cuthbertson DJ, Smith K, et al. Collagen synthesis in human musculoskeletal tissues and skin. Am J Physiol Endocrinol Metab. 2005;289:E864-E869. (Pubitemid 41504387)
41. Meier-Augenstein W. Applied gas chromatography coupled to isotope ratio mass spectrometry. J Chromatogr A. 1999;842:351-371. (Pubitemid 29229893)
42. Babraj J, Cuthbertson DJ, Rickhuss P, et al. Sequential extracts of human bone show differing collagen synthetic rates. Biochem Soc Trans. 2002; 30:61-65.
43. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem. 1984;141:101-109.
44. Rennie MJ, Edwards RH, Halliday D, Matthews DE, Wolman SL, Millward DJ. Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond). 1982;63:519-523. (Pubitemid 13213942)
45. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endo-crinol Metab. 1999;84:3666-3672. (Pubitemid 30645223)
46. Lee CE, McArdle A, Griffiths RD. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr. 2007;26:524-534. (Pubitemid 47618317)
47. Dela F, Kjaer M. Resistance training, insulin sensitivity and muscle function in the elderly. Essays Biochem. 2006;42:75-88.
48. Sipila S, Heikkinen E, Cheng S, et al. Endogenous hormones, muscle strength, and risk of fall-related fractures in older women. J Gerontol A Biol Sci Med Sci. 2006;61:92-96. (Pubitemid 43227806)
49. Roeder RA, Thorpe SD, Byers FM, Schelling GT, Gunn JM. Infl uence of anabolic agents on protein synthesis and degradation in muscle cells grown in culture. Growth. 1986;50:485-495. (Pubitemid 17090049)
50. Mauras N. Effects of estrogen therapy on whole body proteins. J Clin Endocrinol Metab. 1996;81:431. (Pubitemid 26035057)
51. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older post-menopausal women: a clinical research center study. J Clin Endocrinol Metab. 1996;81:2848-2853. (Pubitemid 26323876)
52. Campagnoli C, Biglia N, Altare F, et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol. 1993;7:251-258. (Pubitemid 24042454)
53. Musaro A, McCullagh K, Paul A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet. 2001;27:195-200. (Pubitemid 32157448)
54. Alzghoul MB, Gerrard D, Watkins BA, Hannon K. Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J. 2004;18:221-223.
55. Fryburg DA, Jahn LA, Hill SA, Oliveras DM, Barrett EJ. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J Clin Invest. 1995;96:1722-1729.
56. Berggren A, Ehrnborg C, Rosen T, Ellegard L, Bengtsson BA, Caidahl K. Short-term administration of supraphysiologic rhGH does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-IGF-1 axes. J Clin Endocrinol Metab. 2005;90:3268-3273. (Pubitemid 41014285)
57. Baar K, Hamilton DL, Philp A. Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Irrelevant growth factor-I. J Appl Physiol. 2010;108:1827.
58. Ehrnborg C, Ellegard L, Bosaeus I, Bengtsson BA, Rosen T. Supra-physiological growth hormone: less fat, more extracellular fl uid but uncertain effects on muscles in healthy, active young adults. Clin Endo-crinol (Oxf). 2005;62:449-457.
59. Lange KH, Andersen JL, Beyer N, et al. GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab. 2002;87:513-523. (Pubitemid 34158213)
60. Yarasheski KE, Zachweija JJ, Angelopoulos TJ, Bier DM. Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. J Appl Physiol. 1993;74:3073-3076. (Pubitemid 23201347)
61. Brown GA, Vukovich M, King DS. Testosterone prohormone supplements. Med Sci Sports Exerc. 2006;38:1451-1461.
62. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007; 92:3040-3043. (Pubitemid 47236368)
63. Dieli-Conwright CM, Spektor TM, Rice JC, Schroeder ET. Hormone therapy attenuates exercise-induced skeletal muscle damage in post-menopausal women. J Appl Physiol. 2009;107:853-858.
64. Miller BF, Hansen M, Olesen JL, et al. No effect of menstrual cycle on myofi brillar and connective tissue protein synthesis in contracting skeletal muscle. Am J Physiol Endocrinol Metab. 2006;290:163-168.
65. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev. 2004;84:649-698. (Pubitemid 38365495)
66. Neugarten J, Medve I, Lei J, Silbiger SR. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol. 1999;277:F875-F881. (Pubitemid 30046062)
67. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas. 1996;24: 197-204.
68. Dahlgren LA, van der Meulen MC, Bertram JE, Starrak GS, Nixon AJ. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res. 2002;20:910-919.
69. Holm L, van HG, Rose AJ, et al. Contraction intensity and feeding affect collagen and myofi brillar protein synthesis rates differently in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010;298: E257-E269.